Leproust Emily M.: insider trades.
Leproust Emily M. reported 38 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 0 open-market purchases and 34 sales ($82.2M), across 1 company.
- Transactions
- 38
- Purchases (P)
- 0
- Sales (S)
- 34
- Companies
- 1
- Name as filed
- Leproust Emily M.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Twist Bioscience Corp (TWST) | Director, Officer · Chief Executive Officer | 38 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-24 | Twist Bioscience Corp | S | 16 | $182.5 | 614,283 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 501 | $183.76 | 613,782 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 21 | $181.45 | 614,299 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 515 | $180.39 | 614,320 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 143 | $179.93 | 614,835 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 330 | $178.67 | 614,978 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 164 | $177.17 | 615,308 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 945 | $176.39 | 615,472 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 2,485 | $175.23 | 616,417 | Form 4 |
| 2026-09-24 | Twist Bioscience Corp | S | 83 | $184.6 | 613,699 | Form 4 |
| 2026-09-21 | Twist Bioscience Corp | S | 1,687 | $165.49 | 618,902 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 4,175 | $154.17 | 960,477 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 2,565 | $162.31 | 621,458 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 11,169 | $161.49 | 624,023 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | M | 133,269 | $26.66 | 901,696 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | M | 75,439 | $8.82 | 977,135 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 2,440 | $151.46 | 974,695 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 6,644 | $152.21 | 968,051 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 3,399 | $153.4 | 964,652 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 869 | $163.39 | 620,589 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 13,378 | $155.46 | 947,099 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 9,097 | $156.47 | 938,002 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 32,260 | $157.49 | 905,742 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 232,173 | $158.09 | 673,569 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 23,884 | $159.53 | 649,685 | Form 4 |
| 2026-09-17 | Twist Bioscience Corp | S | 14,493 | $160.44 | 635,192 | Form 4 |
| 2026-09-08 | Twist Bioscience Corp | S | 2,302 | $122.62 | 768,427 | Form 4 |
| 2026-08-25 | Twist Bioscience Corp | S | 9,181 | $153.93 | 771,822 | Form 4 |
| 2026-08-25 | Twist Bioscience Corp | S | 6,412 | $152.75 | 781,003 | Form 4 |
| 2026-08-25 | Twist Bioscience Corp | S | 12,236 | $151.36 | 787,415 | Form 4 |
| 2026-08-25 | Twist Bioscience Corp | S | 12,648 | $150.56 | 799,651 | Form 4 |
| 2026-08-25 | Twist Bioscience Corp | S | 1,093 | $154.45 | 770,729 | Form 4 |
| 2026-08-21 | Twist Bioscience Corp | S | 6,639 | $139.07 | 812,299 | Form 4 |
| 2026-08-12 | Twist Bioscience Corp | M | 19,952 | $26.66 | 838,890 | Form 4 |
| 2026-08-12 | Twist Bioscience Corp | S | 19,952 | $125.08 | 818,938 | Form 4 |
| 2026-08-10 | Twist Bioscience Corp | S | 113,318 | $125.16 | 818,938 | Form 4 |
| 2026-08-10 | Twist Bioscience Corp | M | 113,318 | $26.66 | 932,256 | Form 4 |
| 2026-08-03 | Twist Bioscience Corp | S | 5,101 | $85.32 | 818,938 | Form 4 |
Questions
What stock did Leproust Emily M. buy or sell?
Leproust Emily M. reported 38 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 0 open-market purchases and 34 sales ($82.2M), across 1 company.
Is Leproust Emily M. the same person as other filers with this name?
This page covers SEC CIK 1753655 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/leproust-emily-m-1753655.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.